A

Allogene (ALLO)

$000.00 0.00% ($0.00)

Today
Week
Month
Year
5 Year
YTD

baraka

getbaraka.com

About Allogene (ALLO)

Allogene Therapeutics, Inc. is a clinical stage immuno-oncology company. The Company is focused on developing and commercializing of allogeneic T cell therapies for the treatment of cancer. It is involved in developing a pipeline of multiple allogene... Read more

Open
USD1.19
High
USD1.28
Low
USD1.15
52 Week High
USD3.78
Monthly Return
-18.30%
Revenue
0M

Daily Vol.
3.79M
Avg. Daily Vol.
3.03M
Market Cap.
372M
52 Week Low
1.09
Annual Return
-59.40%

Stock News

U.S. and China conclude two days of ‘productive’ trade talks, Bessent says

U.S. and China conclude two days of ‘productive’ trade talks, Bessent says

MarketWatch

Trump poised to accept Qatar jet gift as Air Force One

Trump poised to accept Qatar jet gift as Air Force One

CNBC

Here are the 3 things we're watching in the stock market in the week ahead

Here are the 3 things we're watching in the stock market in the week ahead

CNBC

Invesco Corporate Bond Fund Q1 2025 Commentary

Invesco Corporate Bond Fund Q1 2025 Commentary

SeekingAlpha

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.

Build Your Long Term Wealth

Build Your Long Term Wealth

A modern investment app with fair pricing.

Top Movers

This list tracks the stocks with the most upwards (top gainers) and downwards (top losers) movement in price from the previous day.

Not sure which stock to invest in?

Not sure which stock to invest in?

Get access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.